China Traditional Chinese Medicine Holdings Dividends and Buybacks
Dividend criteria checks 0/6
China Traditional Chinese Medicine Holdings does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | 0% |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | HK$0.0516 |
Payout ratio | 21% |
Recent dividend and buyback updates
Recent updates
China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable
Jan 04Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?
Oct 23Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Aug 23Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?
May 22China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year
Dec 08These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively
Sep 05China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially
Jul 20Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Jul 18Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock
Jun 01Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly
Apr 28Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)
Feb 14Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock
Jan 11Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly
Dec 05China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate
Oct 29I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease
Oct 11These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Reasonably Well
Aug 24Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?
Jul 13China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jun 25Does China Traditional Chinese Medicine Holdings (HKG:570) Deserve A Spot On Your Watchlist?
Apr 04Are Investors Undervaluing China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) By 30%?
Mar 15China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 22China Traditional Chinese Medicine Holdings (HKG:570) Shareholders Have Enjoyed A 19% Share Price Gain
Feb 01What Percentage Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Do Insiders Own?
Dec 18Is China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Trading At A 33% Discount?
Dec 03Declining Stock and Decent Financials: Is The Market Wrong About China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)?
Nov 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 570's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 570's dividend payments have been increasing.
Dividend Yield vs Market
China Traditional Chinese Medicine Holdings Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (570) | n/a |
Market Bottom 25% (HK) | 3.1% |
Market Top 25% (HK) | 7.9% |
Industry Average (Pharmaceuticals) | 3.6% |
Analyst forecast (570) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate 570's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 570's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 570 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 570 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/24 07:55 |
End of Day Share Price | 2025/02/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
China Traditional Chinese Medicine Holdings Co. Limited is covered by 21 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ling Zhang | BNP Paribas Securities (Asia) |
Helena Qiu | CCB International Securities Limited |
Yue-Kwong Lui | CGS International |